Pupillary Changes as a Potential Biomarker for Escitalopram in Relation to CYP2C19 Polymorphism
Clinical trial NCT00397059 · COMPLETED
Trial details
- NCT number
- NCT00397059
- Sponsor
- University of Southern Denmark
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2007-10-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.